Why is Vaishali Pharma falling/rising?

As of 17-Sep, Vaishali Pharma Ltd's stock price is currently at 12.06, reflecting a slight increase of 0.02 or 0.17%. Today's price summary indicates that the stock's performance is in line with its sector, although it is higher than the 5-day moving averages but lower than the 20-day, 50-day, 100-day, and 200-day moving averages. Despite a recent rise in investor participation, with delivery volume increasing by 133.19% compared to the 5-day average, the company faces significant challenges. The stock has shown a substantial decline of 39.40% over the past year, and its operating profits have decreased dramatically, leading to a weak long-term fundamental strength. The company's ability to service its debt is also concerning, with a poor EBIT to Interest ratio and negative EBITDA, which further complicates its financial outlook.
In the broader market context, the stock's short-term performance over the past week shows a modest gain of 0.08%, while the benchmark Sensex has increased by 1.43% during the same period. This underperformance is indicative of the stock's struggles, as it has consistently lagged behind the benchmark in both short-term and long-term returns. The company's flat results in June, alongside a significant drop in profit after tax, highlight ongoing operational difficulties that contribute to its overall negative performance. Given these factors, while there may be a slight uptick in price, the underlying fundamentals suggest a challenging environment for Vaishali Pharma Ltd.